C Papaconstantinou - JoVE Visualize

Showing results (11-20 of 12) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 12 results.

Anti-Cancer Drugs|November 29, 2012

Steroidal esters of the aromatic nitrogen mustard 2-[4-N,N-bis(2-chloroethyl)amino-phenyl]butanoic acid (2-PHE-BU): synthesis and in-vivo biological evaluationIoanna C Papaconstantinou, Manolis A Fousteris, Anna I Koutsourea, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000

Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG)P Kosmidis, N Mylonakis, D Skarlos, et al.

Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 12 results.

Anti-Cancer Drugs|November 29, 2012

Steroidal esters of the aromatic nitrogen mustard 2-[4-N,N-bis(2-chloroethyl)amino-phenyl]butanoic acid (2-PHE-BU): synthesis and in-vivo biological evaluationIoanna C Papaconstantinou, Manolis A Fousteris, Anna I Koutsourea, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000

Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG)P Kosmidis, N Mylonakis, D Skarlos, et al.

Pageof 2